Suscribirse

Continual Decrease in Blood Lead Level in Americans: United States National Health Nutrition and Examination Survey 1999-2014 - 21/10/16

Doi : 10.1016/j.amjmed.2016.05.042 
Man-Fung Tsoi, BSc a, Ching-Lung Cheung, PhD a, b, c, d, Tommy Tsang Cheung, MRCP a, b, Bernard Man Yung Cheung, PhD a, b, c, e,
a Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Pokfulam, China 
b Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Pokfulam, China 
c Partner State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, China 
d Department of Pharmacology and Pharmacy, The University of Hong Kong, Pokfulam, China 
e Institute of Cardiovascular Science and Medicine, The University of Hong Kong, Pokfulam, China 

Requests for reprints should be addressed to Bernard Man Yung Cheung, PhD, University Department of Medicine, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.University Department of MedicineQueen Mary Hospital102 Pokfulam RoadHong KongChina

Abstract

Background

Lead is toxic and affects neurodevelopment in children even at low levels. There has been a long-term effort in the United States to reduce exposure to lead in the environment. We studied the latest US population blood lead levels and analyzed its trend.

Method

Blood lead levels in 63,890 participants of the National Health Nutrition and Examination Survey 1999-2014 were analyzed using SPSS Complex Samples v22.0 (IBM Corp, Armonk, NY).

Results

Mean blood lead levels and 95% confidence intervals (CIs) were 1.65 μg/dL (1.62-1.68), 1.44 μg/dL (1.42-1.47), 1.43 μg/dL (1.40-1.45), 1.29 μg/dL (1.27-1.32), 1.27 μg/dL (1.25-1.29), 1.12 μg/dL (1.10-1.14), 0.97 μg/dL (0.95-0.99), and 0.84 μg/dL (0.82-0.86) in 1999-2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, and 2013-2014, respectively. Blood lead levels decreased significantly (P <.001), and the trend remained significant when stratified by age, gender, ethnicity, and pregnancy status (P <.05). Estimated percentages of children with blood lead level ≥5 μg/dL were 9.9% (95% CI, 7.5-12.9), 7.4% (95% CI, 5.9-9.4), 5.3% (95% CI, 4.1-6.9), 2.9% (95% CI, 2.1-3.9), 3.1% (95% CI, 2.0-4.8), 2.1% (95% CI, 1.5-3.1), 2.0% (95% CI, 1.0-3.6), and 0.5% (95% CI, 0.3-1.0) in 1999-2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, and 2013-2014, respectively. The decreasing trend was significant (P <.05). In children aged 1 to 5 years in the National Health Nutrition and Examination Survey 2011-2014, the estimated 97.5 percentile of blood lead level was 3.48 μg/dL.

Conclusions

Blood lead levels have been decreasing in the US population. The reference level also should decrease. It is still important to monitor blood lead levels in the population, especially among pregnant women and children aged 1 to 5 years.

El texto completo de este artículo está disponible en PDF.

Keywords : Blood lead level, NHANES


Esquema


 Funding: None.
 Conflict of Interest: None.
 Authorship: All authors had access to the data and played a role in writing this manuscript.


© 2016  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129 - N° 11

P. 1213-1218 - novembre 2016 Regresar al número
Artículo precedente Artículo precedente
  • Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes
  • Stefano Savonitto, Delia Colombo, Nicoletta Franco, Leonardo Misuraca, Laura Lenatti, Ilaria J. Romano, Nuccia Morici, Emilia Lo Jacono, Chiara Leuzzi, Elena Corrada, Tiziana C. Aranzulla, A. Sonia Petronio, Gilberto Bellia, Enrico Romagnoli, Angelo Cagnacci, Giuseppe Biondi Zoccai, Francesco Prati, LADIES ACS Study Investigators
| Artículo siguiente Artículo siguiente
  • Too Fast for Comfort: Tachycardia in Postablation Wolff-Parkinson-White
  • Evelyn B. Ling, Taylor L. Stayton, Benjamin R. Stripe, Uma Srivatsa, Ezra A. Amsterdam, Sandhya Venugopal

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.